Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Sorafenib
Related studies linked through entity extraction aliases.
Phase II Open Label, Non-randomized Study of Sorafenib and Everolimus in Relapsed and Non-resectable Osteosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) Plus Sorafenib in Patients With Unresectable Hepatocellular Carcinoma (HCC)
- Status
- WITHDRAWN
- Phase
- PHASE1
Sorafenib + mFOLFOX for Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy and Safety Study of Sorafenib to Treat Advanced Medullary Thyroid Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Whole Brain Radiotherapy (WBRT) With Sorafenib for Breast Cancer Brain Metastases (BCBM)
- Status
- COMPLETED
- Phase
- PHASE1
The Effect of Sorafenib on Portal Pressure
- Status
- COMPLETED
- Phase
- PHASE2
Activity of Sorafenib in Salivary Gland Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Determination of Intratumoral Concentrations of Kinase Inhibitors in Patients With Advanced Solid Malignancies.
- Status
- COMPLETED
- Phase
- NA
Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Radiation Therapy With Sorafenib for TACE-Resistant Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of Curcumin, Vorinostat, and Sorafenib
- Status
- WITHDRAWN
- Phase
- PHASE1
Sorafenib Tosylate Before and After Donor Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1